Angiotech gets gynaecology study boost for anti-adhesion gel
This article was originally published in Clinica
Executive Summary
Angiotech Pharmaceuticals says that its Adhibit adhesion prevention gel has produced encouraging results in a pivotal European trial that is testing the product's ability to reduce the incidence and severity of adhesions following laparoscopic surgery in a gynaecological population.